Purchase Order 75N92B25P00233
Award Date
8/25/25
Potential Completion Date
2/24/26
Potential Value
$24K
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price Delivery Order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment and reagents. The $146,891.73 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, and support services. This award...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 sequencer. This $248,412.08 contract supports the sequencing operations of NIAMS' core research facility. There is no...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis solutions, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH). The $199,073.27 firm-fixed price Delivery Order contract is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. This award was not subject to small business set-aside...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $197,834.87 contract provides Illumina's NextSeq 2000 and 1000/2000 sequencing reagents to support life science research and diagnostics. This award is not associated with a set-aside program. Illumina has a history...
The National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $197,925 firm fixed price contract to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment, for the Illumina NextSeq 2000 Sequencing System. This non-competitive purchase order is intended to replace NIAMS' existing Illumina NextSeq 550 sequencer, enabling higher sequencing throughput and capacity to support the agency's genomics research program....
This federal contract award, valued at $491,802.34, was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents, on a firm fixed price basis. The award is a delivery order for "01-MISEQ REAGENT KIT V2 (300 CYCLE)" and does not have a set-aside designation....
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order contract worth $247,444.82 to Illumina, Inc. to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing instruments. The contract has a completion date of September 2, 2025. Illumina is a manufacturer of genetic and genomic analysis instruments and...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 2000 sequencers. The $202,227.89 award has a completion date of September 2, 2025 and does not utilize any set-aside designations....
This firm fixed-price delivery order was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $93,769.11 contract is for the provision of Illumina's proprietary NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. This award is not associated with a set-aside program....
This federal contract award was made by the Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing products and services. The $135,680.40 firm fixed price delivery order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, and support services. The contract has no...